Indaptus Therapeutics Competitors and Similar CompaniesClear all

Indaptus Therapeutics's competitors and similar companies include Seagen, Opsy and OnCusp Therapeutics.

	Indaptus Therapeutics Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread.	OnCusp Therapeutics OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions.
Founding Date	Founding Date 2021	Founding Date 1998	Founding Date 2007	Founding Date 2021
Type	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare oncology pharma therapy	Tags Healthcare oncology pharma therapy
Locations	Locations HQ	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Gothenburg, SE HQ Lund, SE	Locations New York, US HQ Shanghai, CN Shanghai, CN
Employees	Employees N/A	Employees 3,25622% increase	Employees 2	Employees 2519% increase
Valuation ($)	Valuation ($) 12.6 m	Valuation ($) N/A	Valuation ($) 721.5 k	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2022)	Revenue (est.) kr6.7m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $410.1m (FY, 2022)	Cost of goods kr1.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $1.6b (FY, 2022)	Gross profit kr5.4m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($610.3m) (FY, 2022)	Net income (kr17.2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 164m	Total funding raised N/A	Total funding raised $ 125m